Nov 29, 2018 - Investors need to pay close attention to EyePoint Pharmaceuticals (EYPT) stock based on the movements in the options market lately.
Nov 06, 2018 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2019 Results Conference Call November 06, 2018 08:00 AM ET Executives Nancy Lurker - President and Chief Executive Officer David Price - Chief Financial
Oct 17, 2018 - EyePoint (EYPT) gains an FDA approval for its eye therapy Yutiq to help cure chronic non-infectious uveitis affecting the posterior segment of the eye.
Oct 01, 2018 - Investors need to pay close attention to EyePoint Pharmaceuticals (EYPT) stock based on the movements in the options market lately.
Sep 12, 2018 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2018 Earnings Conference Call September 12, 2018 08:30 AM ET Executives David Price - CFO Nancy Lurker - President and CEO Leonard Ross - VP, Finance an
Sep 12, 2018 - EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -111.11% and 6.72%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Jun 01, 2018 - Passage of the Right To Try law and WHO's focus on assessing the quality of bio-similar drugs is expected to benefit biotech stocks.
May 08, 2018 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2018 Earnings Conference Call May 8, 2018 4:30 PM ET Executives Barbara Ryan - Head of Investor Relations Nancy Lurker - President and Chief Executive
Apr 20, 2018 - As of late, it has definitely been a great time to be an investor in EyePoint Pharmaceuticals, Inc. (EYPT)